Struggles of HIV-Positive Patients Amid Funding Cuts

Gugu used to pick up her anti-retroviral medication from a clinic in downtown Johannesburg funded by USAID. But when President Trump’s announcements about cuts to aid funding surfaced earlier this year, she, along with many other HIV-positive individuals in South Africa, faced an uncertain future.

Fortunately for Gugu, her clinic reached out to her before it shut down, which was a relief. “I managed to get my medication in bulk before they closed. Normally, I collect a three-month supply, but they handed me nine months’ worth this time,” she shared.

However, by September, she will run out of her antiretrovirals and plans to visit her local public hospital. At 54, Gugu, a former sex worker, learned she was HIV-positive after leaving the industry. She had a persistent cough that she initially thought was tuberculosis. After visiting a doctor who misdiagnosed her with a chest infection, she sought an HIV test at a clinic.

“By then, I was already suspecting I might have HIV,” she recalled. Her assumption turned out to be correct, and she’s been on treatment ever since. For privacy reasons, we’re using a pseudonym for her.

Currently, Gugu works as a project coordinator for a non-profit organization. The NGO focuses on supporting pregnant sex workers with access to ARVs, ensuring their newborns remain HIV-negative. They also conduct home visits to help mothers manage their medication schedules and care for their infants during routine check-ups.

Before the funding cuts, many HIV-positive sex workers depended on private clinics backed by the now-disbanded USAID. However, most of these facilities had to close following the foreign aid reductions initiated by the Trump administration.

A forthcoming report from a UN agency, while not specifically calling out the US, warns that steep aid cuts from various donors have shaken global efforts against HIV. The report expresses concern that the impressive progress achieved in combating the disease could be compromised.

Since 2010, new HIV infections have plummeted by 40%, and approximately 4.4 million children have been shielded from the virus since 2000. Yet, UNAIDS cautions that without immediate action, the world could see an additional six million new HIV infections and four million AIDS-related deaths by 2029.

While Gugu has been fortunate, her situation highlights broader issues. She notes that many sex workers might hesitate to visit public hospitals. “The problem is the wait time. You have to arrive at the crack of dawn, like 4 or 5 a.m., and may end up waiting all day for your medication. For sex workers, that translates to lost income,” she said.

She recounted a recent trip to a local clinic where the nurse in charge was dismissive, stating that there was nothing distinct about sex workers. This kind of treatment, she fears, could lead many to miss doses of their medication, especially since their hospital records contain sensitive information that clinic staff may not handle with care.

The UN has warned that the US’s funding cuts could undo significant advancements viewed as successes in public health history. Research from a UK medical journal last month indicated that USAID funding has been pivotal, decreasing AIDS deaths by 65%—equating to roughly 25.5 million lives saved over the last two decades.

Historically, the fight against HIV/AIDs gained momentum during George W. Bush’s presidency, who launched a comprehensive initiative in 2003 supporting the global response to the virus. This resulted in over $100 billion invested in combating HIV/AIDs, marking the largest commitment from any nation to address a singular health crisis.

Today, South Africa holds the world’s highest number of HIV-positive individuals, approximately 7.7 million, with around 5.9 million receiving treatment. The South African government estimates that Pepfar funding contributed significantly—about 17%—to its national HIV program, which included mobile clinics to enhance access to care.

The recent cuts have raised alarms that infection rates could rise again. Professor Lynn Morris from Wits University expressed concerns, stating, “We’re likely to see a spike in HIV infections and other infectious diseases, reversing a previously optimistic trend in addressing these issues.”

Gugu emphasized how crucial access to treatment is for vulnerable groups like sex workers. “People are terrified of defaulting on their ARVs because that could cost them their lives,” she reflected.

The funding reductions have additionally hindered efforts to research an HIV vaccine and develop a cure. “We’re missing out on critical opportunities for advancements in this field, especially concerning surveillance for emerging viruses,” noted Professor Morris.

Research institutions in South Africa have been at the forefront of HIV studies, with many innovative treatments, such as PrEP, tested there. Another promising drug, Lenacapavir, which provides substantial protection against HIV, was also trialed within the country.

Back at Wits University, a small team continues its efforts to create an HIV vaccine. Part of the Brilliant Consortium, they are collaborating across eight African nations. Associate Professor Abdullah Ely mentioned, “Our goal was to design a vaccine to benefit our communities and address this issue effectively.”

However, the recent US funding cuts have cast uncertainty over their research plans. “The halt means much of our progress is set back months, if not years. It’s a considerable blow to both South Africa and the continent,” he said.

In June, universities requested a rescue package of 4.6 billion rand ($260 million) over three years to mitigate the impact of lost funding. Dr. Phethiwe Matutu, head of Universities South Africa, highlighted that “South Africa leads in HIV research, but it shouldn’t be just for its benefit. The implications are global.”

In response to these challenges, South Africa’s Health Minister Aaron Motsoaledi recently announced some alternative funding had been secured, though it’s substantially less than what was sought. The Bill and Melinda Gates Foundation and the Wellcome Trust have stepped forward with donations, but it falls short of addressing the overall need.

As for Gugu, she had once envisioned a time when a cure for HIV/AIDs would emerge during her lifetime, but she finds her optimism waning. “I take care of a nine-year-old, and I want to be around for him for as long as I can,” she shared. “It’s more than just a current problem; it impacts future generations of women and the youth.”